Cargando…
Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer
PURPOSE: Treatment of post-operative pelvic side-wall relapses of cervical cancer has always been a therapeutic challenge for radiation oncologists. Radiation dose boost to recurrent tumor by brachytherapy is necessary, but difficult to achieve. Our treatment center has successfully achieved precise...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782074/ https://www.ncbi.nlm.nih.gov/pubmed/35079249 http://dx.doi.org/10.5114/jcb.2021.112114 |
_version_ | 1784638236284420096 |
---|---|
author | Mamady, Keita Chen, Xi Malick, Bah Fang, Zhaohui Niu, Huixian Bangaly, Traoré Liu, Hong |
author_facet | Mamady, Keita Chen, Xi Malick, Bah Fang, Zhaohui Niu, Huixian Bangaly, Traoré Liu, Hong |
author_sort | Mamady, Keita |
collection | PubMed |
description | PURPOSE: Treatment of post-operative pelvic side-wall relapses of cervical cancer has always been a therapeutic challenge for radiation oncologists. Radiation dose boost to recurrent tumor by brachytherapy is necessary, but difficult to achieve. Our treatment center has successfully achieved precise transvaginal insertion of a pelvic side-wall mass, using a metal tube with real-time ultrasound guidance. This study investigates the efficacy and safety of image-guided high-dose-rate (HDR) interstitial brachytherapy (IBT) for patients with post-operative pelvic side-wall relapses. MATERIAL AND METHODS: Between 2018 and 2020, 36 post-operative pelvic side-wall relapses of cervical cancer patients receiving external beam radiotherapy (EBRT) combined with HDR-IBT were analyzed retrospectively. Doses per fraction ranged from 6.0 to 7.0 Gy, whereas cumulative equivalent doses in 2 Gy fractions ranged from 80 to 100 Gy. Effects of prognostic factors on local control (LC) and progression-free survival (PFS) were analyzed, and late toxicity data were evaluated. RESULTS: A total of thirty-six patients were included, with a median follow-up of 19.3 months. The tumor response was obtained for all patients, with radiological complete remission in 20 (55.6%) patients. Two-years LC and PFS rates were 72.2% and 47.2%, respectively. Grade II rectal toxicity was observed in 5 patients (13.9%). Multivariate analyses for LC and PFS using proportional regression model were performed, in which shape of exophytic tumor was associated with a significantly better prognosis for both LC and PFS (HR = 0.071, 0.128, p = 0.005, 0.002). Clinical target volume (CTV) D(90) remained associated with a significantly better prognosis for PFS (HR = 0.056, p = 0.000). CONCLUSIONS: A metal tube placed in the vagina, under the guidance of real-time ultrasound in transvaginal IBT for pelvis masses can be accurately achieved. The shape of exophytic tumor and CTV D(90) were associated with a significantly better prognosis for PFS, and the shape of exophytic tumor was also associated with a better prognosis for LC. Therefore, radiation dose boost using IBT can improve the prognosis of patients with post-operative pelvic side-wall recurrences of cervical cancer. |
format | Online Article Text |
id | pubmed-8782074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-87820742022-01-24 Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer Mamady, Keita Chen, Xi Malick, Bah Fang, Zhaohui Niu, Huixian Bangaly, Traoré Liu, Hong J Contemp Brachytherapy Original Paper PURPOSE: Treatment of post-operative pelvic side-wall relapses of cervical cancer has always been a therapeutic challenge for radiation oncologists. Radiation dose boost to recurrent tumor by brachytherapy is necessary, but difficult to achieve. Our treatment center has successfully achieved precise transvaginal insertion of a pelvic side-wall mass, using a metal tube with real-time ultrasound guidance. This study investigates the efficacy and safety of image-guided high-dose-rate (HDR) interstitial brachytherapy (IBT) for patients with post-operative pelvic side-wall relapses. MATERIAL AND METHODS: Between 2018 and 2020, 36 post-operative pelvic side-wall relapses of cervical cancer patients receiving external beam radiotherapy (EBRT) combined with HDR-IBT were analyzed retrospectively. Doses per fraction ranged from 6.0 to 7.0 Gy, whereas cumulative equivalent doses in 2 Gy fractions ranged from 80 to 100 Gy. Effects of prognostic factors on local control (LC) and progression-free survival (PFS) were analyzed, and late toxicity data were evaluated. RESULTS: A total of thirty-six patients were included, with a median follow-up of 19.3 months. The tumor response was obtained for all patients, with radiological complete remission in 20 (55.6%) patients. Two-years LC and PFS rates were 72.2% and 47.2%, respectively. Grade II rectal toxicity was observed in 5 patients (13.9%). Multivariate analyses for LC and PFS using proportional regression model were performed, in which shape of exophytic tumor was associated with a significantly better prognosis for both LC and PFS (HR = 0.071, 0.128, p = 0.005, 0.002). Clinical target volume (CTV) D(90) remained associated with a significantly better prognosis for PFS (HR = 0.056, p = 0.000). CONCLUSIONS: A metal tube placed in the vagina, under the guidance of real-time ultrasound in transvaginal IBT for pelvis masses can be accurately achieved. The shape of exophytic tumor and CTV D(90) were associated with a significantly better prognosis for PFS, and the shape of exophytic tumor was also associated with a better prognosis for LC. Therefore, radiation dose boost using IBT can improve the prognosis of patients with post-operative pelvic side-wall recurrences of cervical cancer. Termedia Publishing House 2021-12-30 2021-12 /pmc/articles/PMC8782074/ /pubmed/35079249 http://dx.doi.org/10.5114/jcb.2021.112114 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Original Paper Mamady, Keita Chen, Xi Malick, Bah Fang, Zhaohui Niu, Huixian Bangaly, Traoré Liu, Hong Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title | Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title_full | Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title_fullStr | Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title_full_unstemmed | Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title_short | Value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
title_sort | value of tube combined with real-time ultrasound-guided accurate interstitial high-dose-rate brachytherapy for post-operative pelvic side-wall recurrences of cervical cancer |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782074/ https://www.ncbi.nlm.nih.gov/pubmed/35079249 http://dx.doi.org/10.5114/jcb.2021.112114 |
work_keys_str_mv | AT mamadykeita valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT chenxi valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT malickbah valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT fangzhaohui valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT niuhuixian valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT bangalytraore valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer AT liuhong valueoftubecombinedwithrealtimeultrasoundguidedaccurateinterstitialhighdoseratebrachytherapyforpostoperativepelvicsidewallrecurrencesofcervicalcancer |